02.08.18
Marketers of opioid cessation products received warning letters from the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC), cautioning them about unproven claims for the treatment of opioid addiction and withdrawal.
Applying last year’s U.S. Supreme Court decision in Bristol-Myers Squibb Co. v. Superior Court of California, an Illinois federal court dismissed nationwide class claims against NBTY, Inc., for lack of jurisdiction.
Once was enough, the U.S. Supreme Court signaled when it denied a writ of certiorari filed by Spokeo, Inc., seeking further clarification on Article III standing.
02.01.18
Citing a link between advertisements and an unrealistic body image, CVS announced that the national pharmacy chain will no longer use touched-up images in advertisements for its beauty products.
After StubHub.com declined to comply with the National Advertising Division’s recommendations with regard to its pricing claims, the self-regulatory body referred the issue to the Federal Trade Commission (FTC) for review.
The Federal Trade Commission (FTC) reached a deal with a company and its CEO over false and unsupported claims that its products could help patients with the side effects of cancer.
The New York legislature is weighing a new bill that would expand the state’s publicity rights law—and the Association of National Advertisers (ANA) is pushing back.
01.25.18
Businesses dodged a major blow when the Tax Cuts and Jobs Act, signed into law by President Donald Trump in December 2017, passed without restrictions on advertising deductions.
In its first case involving connected toys, the Federal Trade Commission (FTC) announced a settlement with VTech Electronics over allegations that the company violated the Children’s Online Privacy Protection Act (COPPA).
To end an action filed by a California city attorney and several district attorneys who challenged its automatic renewal practices, eHarmony agreed to pay up to $2.2 million in penalties and restitution.